Price (delayed)
$2.27
Market cap
$31.88M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.77
Enterprise value
$35.89M
Cumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and products conceived at
There are no recent dividends present for CPIX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.